Can I Take Quercetin with Synthroid (Levothyroxine)?

What Is Quercetin and Why Do Women Take It?

Quercetin is a flavonoid found in onions, apples, capers, and green tea. It is widely sold as a supplement, typically in doses ranging from 250 mg to 1,000 mg per day, and marketed for immune support, allergy relief, and anti-inflammatory effects. Clinical pharmacology reviews confirm quercetin inhibits several cytochrome P450 enzymes, including CYP3A4, CYP1A2, and CYP2C9, which is where the concern for levothyroxine users begins.

Women reach for quercetin for a specific set of reasons that overlap heavily with conditions also associated with thyroid dysfunction.

Why Women in Particular Use Quercetin

• Allergy and histamine symptoms. Quercetin has antihistamine-like properties that appeal to women managing seasonal allergies or mast cell-related symptoms.
• Perimenopausal inflammation. Some women in perimenopause take quercetin hoping to reduce the low-grade inflammation that accompanies estrogen withdrawal.
• PCOS management. A 2021 randomized controlled trial in women with PCOS found that 500 mg/day of quercetin for 12 weeks significantly reduced fasting insulin and testosterone, which has driven interest in this population.
• Bone protection. Early data suggest quercetin may support osteoblast activity, relevant to postmenopausal women at risk for osteoporosis.

The problem: hypothyroidism affects roughly 5% of the U.S. Population, with women diagnosed at a rate five to eight times higher than men. A meaningful proportion of women taking quercetin are also on levothyroxine, making this interaction clinically relevant.

How Levothyroxine Works and Why Its Absorption Is Fragile

Levothyroxine (sold as Synthroid, Tirosint, Euthyrox, and generics) replaces the thyroxine (T4) your thyroid gland no longer produces in adequate amounts. It has an extremely narrow therapeutic index. A TSH shift from 1.5 to 4.5 mIU/L, which can happen with a relatively small change in absorption, changes how you feel and carries real clinical consequences over months and years.

What Makes Levothyroxine Absorption Unusually Vulnerable

Levothyroxine is best absorbed in an acidic, empty-stomach environment. FDA labeling for levothyroxine states that the drug should be taken on an empty stomach, 30 to 60 minutes before food, and separated from calcium, iron, antacids, and other agents known to reduce absorption. The jejunum absorbs approximately 60 to 80% of an oral dose under ideal conditions. Anything that alters gastric pH, binds the drug in the gut, or speeds intestinal transit can reduce that fraction.

Quercetin is a polyphenol with moderate protein-binding capacity. In vitro studies show it can bind directly to thyroid hormone transport proteins, including thyroxine-binding globulin (TBG), which could in theory compete with T4 for binding sites and alter free hormone availability. This is a pharmacodynamic concern layered on top of the pharmacokinetic one.

T4 to T3 Conversion: Where CYP Enzymes Enter

T4 is largely a prohormone. It must be converted to the active triiodothyronine (T3) by deiodinase enzymes, but hepatic CYP enzymes also play a role in thyroid hormone clearance and sulfation. In vitro research published in Pharmaceutical Research demonstrated that quercetin inhibits CYP3A4 with an IC50 in the low micromolar range, concentrations that may be approached in gut tissue even if systemic plasma levels remain lower. Inhibiting CYP3A4 could slow T4 clearance, raising free T4, but simultaneously slowing conversion pathways could reduce active T3 availability. The net clinical effect in any individual woman is unpredictable without monitoring.

The Evidence: What Do We Actually Know?

The honest answer is that the direct human pharmacokinetic data on quercetin plus levothyroxine does not yet exist in a form that allows precise dose adjustment guidance. This is a gap you deserve to know about.

Animal and In Vitro Data

A rodent study published in Phytotherapy Research found that quercetin administration altered serum T3 and T4 levels in rats, with higher doses suppressing thyroid hormone output. The mechanism appeared to involve inhibition of thyroid peroxidase (TPO) activity. TPO is the enzyme that incorporates iodine into thyroglobulin to produce thyroid hormones. Women with Hashimoto's thyroiditis, where TPO antibodies are already attacking this enzyme, may face compounded risk if quercetin further reduces TPO activity.

Human Observational and Mechanistic Data

No published randomized controlled trial has directly measured TSH, free T4, or free T3 change in hypothyroid women taking a fixed levothyroxine dose before and after adding quercetin at typical supplement doses. This is a meaningful evidence gap. What exists includes:

• Case reports in pharmacovigilance databases of TSH elevation in patients adding flavonoid-rich supplements.
• A 2020 review in the Journal of Thyroid Research documenting that multiple dietary flavonoids, including quercetin and kaempferol, inhibit sodium-iodide symporter (NIS) activity and TPO in human thyroid cell lines.
• Mechanistic modeling data suggesting quercetin's intestinal CYP3A4 inhibition could increase the oral bioavailability of co-administered drugs by 20 to 40% depending on dosage form and timing.

The directionality of the interaction is therefore bidirectional depending on the mechanism you focus on: absorption-phase inhibition of levothyroxine chelation or binding, which could reduce bioavailability; versus CYP inhibition in the intestinal wall, which could increase it. Your TSH tells the real story, which is why monitoring is non-negotiable.

The WomanRx Interaction Triage Framework for Quercetin Plus Levothyroxine:

| Risk Level | Clinical Profile | Recommended Action | |---|---|---| | Low | Stable TSH, no autoimmune thyroid disease, quercetin <500 mg/day, dose-separated by 4+ hours | Recheck TSH in 6-8 weeks | | Moderate | Hashimoto's thyroiditis, pregnancy planning, perimenopausal with fluctuating TSH | Discuss with prescriber first; recheck TSH in 4-6 weeks | | High | Pregnancy, thyroid cancer on suppression therapy, TSH already suboptimal | Avoid quercetin until thyroid status is stable; consult endocrinologist |

Sex-Specific Physiology: Why This Matters Differently Across Your Life

Thyroid disease is a women's disease in terms of epidemiology. The interaction between quercetin and levothyroxine carries different weight depending on where you are in your reproductive life.

Reproductive Years (Ages 18-40)

If you are menstruating and on levothyroxine, your TSH targets are the same as the general adult range (0.4 to 4.0 mIU/L by most lab references), but your thyroid hormone needs fluctuate slightly across the menstrual cycle due to estrogen's effect on TBG. Adding a CYP and absorption modifier during this time may make TSH harder to interpret mid-cycle. Schedule your TSH check for the same phase of your cycle each time, ideally early follicular, for the most consistent read.

Trying to Conceive and Preconception

ACOG and the American Thyroid Association recommend a preconception TSH of <2.5 mIU/L for women with known hypothyroidism who are trying to conceive. Any supplement that destabilizes TSH near that target could reduce your odds of conception or increase early pregnancy loss risk. Stop quercetin, or at minimum confirm your TSH is at target, before actively trying.

Pregnancy

This section is required because levothyroxine is a drug with clear pregnancy implications and quercetin's safety in human pregnancy has not been adequately studied.

Levothyroxine in Pregnancy: Levothyroxine is FDA Pregnancy Category A. It is not only safe but often necessary in pregnancy. Levothyroxine requirements typically increase by 25 to 50% during pregnancy, beginning as early as the fifth week of gestation. Uncontrolled hypothyroidism in pregnancy is associated with miscarriage, preterm birth, placental abruption, and impaired fetal neurodevelopment. Your dose should be adjusted promptly when pregnancy is confirmed.

Quercetin in Pregnancy: There is no established safe dose of quercetin for pregnant women. Animal studies have raised concerns about high-dose quercetin and fetal development, including potential mutagenicity at supraphysiologic doses. Human data are absent. Given that levothyroxine requirements are already shifting rapidly in early pregnancy and that any absorption interference could have fetal consequences, quercetin should be discontinued before conception and avoided throughout pregnancy. This is not a close call.

Lactation: Quercetin is present in breast milk from dietary sources at very low concentrations. Supplemental doses deliver substantially more. No controlled studies have measured supplemental quercetin transfer into human breast milk or infant outcomes. Given the lack of safety data, supplemental quercetin is not recommended during breastfeeding. Levothyroxine itself transfers minimally into breast milk and is safe during lactation at therapeutic doses.

Contraception Note: Levothyroxine is not a teratogen requiring contraception, but the interaction between quercetin and CYP3A4 is relevant if you use hormonal contraception, since many oral contraceptives are also CYP3A4 substrates. Adding a CYP inhibitor could theoretically affect hormone levels from your pill, though the clinical magnitude of this effect for quercetin at standard supplement doses is unknown.

Perimenopause and Postmenopause

Perimenopausal women face a double complexity. Estrogen decline reduces TBG concentrations, which changes the ratio of bound to free T4 and can make previously stable levothyroxine doses feel either too high or too low. If you are also adding quercetin for menopausal symptom relief or bone support, you are introducing a third variable. The Menopause Society (formerly NAMS) does not currently endorse quercetin as a proven treatment for any menopausal symptom, and the evidence for its use in this context is preliminary. Recheck TSH within six weeks of starting quercetin in this life stage.

Postmenopausal women on stable, long-term levothyroxine doses may have less TSH variability overall, but CYP-mediated interactions do not disappear with age. Older women also tend to have lower gastric acid output, which already reduces levothyroxine absorption baseline. Adding quercetin to that environment adds another layer of unpredictability.

Conditions Where This Interaction Deserves Extra Attention

Several conditions common in women create additional reasons to be careful.

Hashimoto's Thyroiditis

Hashimoto's is an autoimmune condition affecting around 5 in 1,000 women per year in the United States and is the leading cause of hypothyroidism in iodine-sufficient regions. Because Hashimoto's already involves antibody-mediated TPO suppression, adding a supplement with in vitro TPO-inhibiting properties is not a theoretically neutral choice. Some integrative practitioners suggest quercetin's anti-inflammatory properties might benefit autoimmune thyroid disease, but there are no published trials in Hashimoto's patients demonstrating benefit, and the mechanistic risk of added TPO inhibition is real. The evidence gap here is particularly wide.

PCOS and Thyroid Co-occurrence

PCOS and autoimmune thyroid disease co-occur in an estimated 20 to 27% of women with PCOS, making this a clinically common combination. If you have PCOS and are drawn to quercetin for its insulin-sensitizing data, and you are also on levothyroxine, you need both a TSH recheck and a conversation with your prescriber before starting.

Thyroid Cancer on Suppressive Therapy

If you are on levothyroxine at suppressive doses (TSH target <0.1 mIU/L for high-risk differentiated thyroid cancer), your therapeutic window is even narrower than for standard hypothyroidism. Any absorption variability that raises TSH above your target could theoretically stimulate residual thyroid tissue or metastases. Quercetin is not appropriate in this setting without explicit oncology team approval.

Practical Guidance: If You Are Already Taking Both

If you are currently taking quercetin and levothyroxine without a TSH check in the past three months, get one now. Specifically:

1. Take levothyroxine first thing in the morning, on an empty stomach, at least 30 to 60 minutes before food or other supplements.
2. Take quercetin with a meal, at least four hours after your levothyroxine dose. Taking it at dinner while your levothyroxine was taken at wake-up gives you the most separation.
3. Request a TSH with free T4 at your next appointment, or use a home thyroid test if your provider supports it. Bring your quercetin bottle to the appointment.
4. If your TSH has shifted by more than 0.5 mIU/L from your personal baseline, flag it. Your prescriber may need to adjust your levothyroxine dose or ask you to stop quercetin.
5. Do not adjust your levothyroxine dose yourself in response to supplement use.

Forms of Quercetin and Whether They Matter

Standard quercetin aglycone is poorly absorbed (bioavailability as low as 1 to 2%). Quercetin phytosome (bound to sunflower phospholipids) and quercetin dihydrate formulations significantly improve oral bioavailability, in some studies by three to fivefold. Higher bioavailability means greater systemic CYP exposure. If you switch from a standard quercetin to a high-absorption formulation, treat it as starting a new supplement and recheck your TSH.

Who This Combination Is and Is Not Right For

May Be Reasonable With Monitoring

• Postmenopausal women with stable Synthroid dosing and no autoimmune thyroid disease, using quercetin <500 mg/day in standard (not enhanced-absorption) form, with dose separation and TSH rechecked in six to eight weeks.
• Women using quercetin for documented allergy symptoms short-term (four to eight weeks), with prescriber awareness.

Use With Significant Caution

• Women with Hashimoto's thyroiditis.
• Perimenopausal women with recently fluctuating TSH.
• Women with PCOS who are also trying to conceive.
• Women using high-bioavailability quercetin formulations at doses above 500 mg/day.

Avoid or Discuss With an Endocrinologist First

• Pregnant women or women actively trying to conceive.
• Breastfeeding women.
• Women on levothyroxine for thyroid cancer suppression.
• Women with a TSH that was already suboptimal (above 3.5 mIU/L or below 0.4 mIU/L) at last check.

What to Tell Your Doctor

Many women do not mention supplements to their prescribers. A CDC survey found that more than 50% of U.S. Adults use at least one dietary supplement, yet disclosure rates to physicians remain below 35%. For a drug as absorption-sensitive as levothyroxine, this gap matters.

Tell your prescriber: "I am taking [dose] mg of quercetin [formulation] once daily at [time]. I started it on [date]. My last TSH was [value] on [date]. I want to make sure my next TSH is checked in six to eight weeks."

That single, specific statement gives your clinician what they need to monitor you appropriately.